Clinical Trials Logo
  1. Home
  2. Parkinson's Disease
  3. NCT00913640
  4. Details
NCT00913640 Clinical Trial

Prospective Memory in Parkinson's Disease

Parkinson's Disease Clinical Trial

— ProMem  

Official title:
Prospective Memory in Parkinson's Disease

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00913640
Other study ID # 05-0203
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 18, 2009
Est. completion date August 27, 2010

Study information
Verified date May 2022
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators tested whether prospective memory is impaired in individuals with Parkinson's Disease compared to controls using reliable and validated experimental measures. Also, the investigators assessed the impact of Parkinson's medication on prospective memory performance in PD to better estimate prospective memory function in PD patients' everyday (chronically treated) life.

Recruitment information / eligibility
Status Completed
Enrollment 52
Est. completion date August 27, 2010
Est. primary completion date August 27, 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria: - PD Group: - Clinically definite PD - 40-70 years old - Hoehn and Yahr stage I,II,III - Currently treated with Levodopa/carbidopa - Control Group: - 40-70 years old - Spouses of PD Group preferred Exclusion Criteria: - PD Group and Control Group: - Significant neurological problems - Significant current psychiatric diagnoses - Mini Mental Status Exam score < 24 (MMSE) - Any significant abnormality on brain imaging - MPTP exposure - Control Participants met the same exclusion criteria described above as well as a biological family history of PD

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Washington University School of Medicine Saint Louis Missouri

Sponsors (2)
Lead Sponsor Collaborator
Washington University School of Medicine National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Foster ER, Rose NS, McDaniel MA, Rendell PG. Prospective memory in Parkinson disease during a virtual week: effects of both prospective and retrospective demands. Neuropsychology. 2013 Mar;27(2):170-81. doi: 10.1037/a0031946. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Virtual Week Prospective Memory Task; Score range is 0-100%, with higher scores being better performance. One session at baseline.
See also
  Status Clinical Trial Phase
Completed NCT02915848 - Long-term Stability of LFP Recorded From the STN and the Effects of DBS
Recruiting NCT03648905 - Clinical Laboratory Evaluation of Chronic Autonomic Failure
Terminated NCT02688465 - Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). Phase 4
Completed NCT05040048 - Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Active, not recruiting NCT04006210 - Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations Phase 3
Completed NCT02562768 - A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease Phase 1
Completed NCT00105508 - Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Phase 3
Completed NCT00105521 - Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Phase 3
Recruiting NCT06002581 - Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease N/A
Completed NCT02236260 - Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation N/A
Completed NCT00529724 - Body Weight Gain, Parkinson, Subthalamic Stimulation Phase 2
Active, not recruiting NCT05699460 - Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
Completed NCT03703570 - A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations Phase 2
Completed NCT03462680 - GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures N/A
Completed NCT02837172 - Diagnosis of PD and PD Progression Using DWI
Not yet recruiting NCT04046276 - Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease N/A
Recruiting NCT02952391 - Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol N/A
Active, not recruiting NCT02937324 - The CloudUPDRS Smartphone Software in Parkinson's Study. N/A
Terminated NCT02894567 - Evaluation of Directional Recording and Stimulation Using spiderSTN N/A
Completed NCT02927691 - Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial Phase 2

External Links